Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company's segment is Pharmaceutical products, including ingredients and intermediaries. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup, and eye/ear drops. Its products under the Carbapenem category are Imipenem 250 (Milligram) mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, and Doripenem 500mg. It offers Penicillins in the form of injections, tablets, and dry syrup. Its general category of products includes liquid injections, dry powder injections and eye/ear drops. Its liquid injections include Iron sucrose 100mg/5ml, Iron sucrose 50mg/2.5ml, Phenytoin sodium 50mg/ml and others. Its dry powder injections include Artesunate 60mg, Artesunate 120mg, Omeprazole 40mg, Rabeprazole 20mg, Pantoprazole 40mg and others.
Brooks Laboratories Ltd FAQs
How to Buy Brooks Laboratories Ltd Share?
To purchase Brooks Laboratories Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Brooks Laboratories Ltd (ticker symbol: BROOKS) on the trading platform provided by your broker and purchase the shares.
What's Brooks Laboratories Ltd share price today?
The stock price of Brooks Laboratories Ltd as of 07 Oct 2025 is ₹125.72
What is the Market Cap of Brooks Laboratories Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Oct 2025, Brooks Laboratories Ltd (ticker symbol: BROOKS) has a market capitalisation of approximately ₹4,00,00,00,000.00
What is the PE and PB ratio of Brooks Laboratories Ltd?
Brooks Laboratories Ltd Ltd's price-to-book ratio as of 07 Oct 2025 is 5.03, reflecting the market's valuation compared to its asset value. As of 07 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is -16.85, indicating the market values the company at around - ₹16.85 for every ₹1 of earnings
What is the 52 Week High and Low of Brooks Laboratories Ltd Share?
Brooks Laboratories Ltd Ltd (BROOKS) hit its 52-week high at ₹173.65, and its 52-week low at ₹95.55.